BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.670

-0.090 (-5.11%)

At close: Feb 27, 2026, 4:00 PM EST

1.650

-0.020 (-1.20%)

After-hours: Feb 27, 2026, 7:40 PM EST

BioXcel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	36.18	29.85	65.22	193.73	232.97	213.12
Cash & Short-Term Investments	36.18	29.85	65.22	193.73	232.97	213.12
Cash Growth	-10.43%	-54.23%	-66.33%	-16.84%	9.31%	557.25%
Accounts Receivable	-	0.13	0.07	0.25	-	-
Receivables	-	0.13	0.07	0.25	-	-
Inventory	0.46	0.68	1.99	1.99	-	-
Prepaid Expenses	5.69	5.29	2.78	3.07	2.89	2.96
Other Current Assets	0.93	1.44	2.08	3.84	0.96	0.98
Total Current Assets	44.4	37.39	72.14	202.87	236.81	217.07
Property, Plant & Equipment	0.39	0.86	1.47	2.06	2.54	2.78
Other Long-Term Assets	-	0.09	0.09	0.93	0.09	0.09
Total Assets	44.79	38.34	73.7	205.85	239.44	219.94
Accounts Payable	16.28	15.99	13.65	10.23	4.68	3.98
Accrued Expenses	4.38	5.78	13.15	22.18	11.39	6.93
Current Portion of Leases	0.16	0.37	-	-	-	-
Current Income Taxes Payable	0.1	0.09	0.12	0.08	0.3	0.7
Other Current Liabilities	0.06	-	0.35	0.4	0.29	0.24
Total Current Liabilities	37.8	22.23	27.27	32.9	16.67	11.84
Long-Term Debt	92.3	102.51	100.6	93.05	-	-
Long-Term Leases	-	0.07	0.44	0.79	1.11	1.4
Other Long-Term Liabilities	3.61	6.63	1.91	2.34	-	-
Total Liabilities	133.71	131.44	130.21	129.08	17.77	13.24
Common Stock	0.07	0.05	0.03	0.03	0.03	0.02
Additional Paid-In Capital	618.56	557.05	534.06	488.29	467.43	345.53
Retained Earnings	-707.55	-650.2	-590.6	-411.55	-245.79	-138.86
Shareholders' Equity	-88.92	-93.1	-56.51	76.78	221.67	206.7
Total Liabilities & Equity	44.79	38.34	73.7	205.85	239.44	219.94
Total Debt	109.29	102.95	101.04	93.84	1.11	1.4
Net Cash (Debt)	-73.11	-73.09	-35.82	99.89	231.86	211.72
Net Cash Growth	-	-	-	-56.92%	9.51%	574.34%
Net Cash Per Share	-9.74	-28.83	-19.67	57.05	140.67	156.23
Filing Date Shares Outstanding	21.87	5.49	1.91	1.81	1.75	1.54
Total Common Shares Outstanding	20	3.1	1.87	1.76	1.75	1.53
Working Capital	6.6	15.16	44.88	169.97	220.15	205.22
Book Value Per Share	-4.45	-30.01	-30.21	43.64	126.76	135.44
Tangible Book Value	-88.92	-93.1	-56.51	76.78	221.67	206.7
Tangible Book Value Per Share	-4.45	-30.01	-30.21	43.64	126.76	135.44
Machinery	0.78	0.78	0.78	0.79	0.74	0.63
Construction In Progress	-	-	-	-	0.02	0.36
Leasehold Improvements	1.2	1.2	1.2	1.18	1.13	0.65

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q